about
Current Trends of Renal Impairment in Multiple MyelomaMethods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic ReviewAssessment of disease activity in systemic vasculitisThe need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort studyInterleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney diseaseMeasurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic reviewDiagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathyThe incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies.Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study.The evolving role of chemokines and their receptors in acute allograft rejection.Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRUHepatitis C and kidney transplantationAllopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKDSerum free light chains and the risk of ESRD and death in CKDThe Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational StudyMacrophages and progressive tubulointerstitial disease.Donor ABCB1 variant associates with increased risk for kidney allograft failure.Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocolEuropean trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial.Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol.The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study.Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation.The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multietSerum free light chain assessment in monoclonal gammopathy and kidney disease.Management options for cast nephropathy in multiple myeloma.Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation.Novel approaches for reducing free light chains in patients with myeloma kidney.Achieving an early myeloma response in patients with kidney impairment.
P50
Q26740444-83B4C599-EA42-40FC-8F01-61B6BCCF45D2Q26783181-B9E9FF22-A027-41AD-9D00-7672F0B26C59Q27485913-39D424D8-D401-4ECD-880E-CBEEC6476C7CQ28541795-0F138E3E-5093-4E9B-BE22-10DCD1159EC7Q30725010-C8754B68-B8F6-420C-902C-4EB1F0860E42Q33220849-921E580A-A6FE-4DC3-ACCE-9D21AA1E443DQ33371085-7D02E0DD-B4A1-4DC6-9B6A-5853F96E2C4CQ33558001-12F7BFB9-A3AC-49D9-8D7B-E4166BD6D16EQ33558001-56C3B566-DBF0-4B48-B93C-5E307DEC510DQ33821915-21686500-A9C0-4F94-863B-04EE24959EA3Q34370957-0104428B-99FB-469D-B8F1-5E89377ECCBBQ34405434-DE572333-9B36-4FF4-AF6D-2CDCBC4901F5Q34675029-F199E677-B70B-45D6-933E-C6B64821B7C2Q34766588-9B4575C9-616E-4621-9C09-5100F3383461Q35012436-A3B98F9D-2521-4435-9589-0851821E3523Q35013404-F1107A91-884C-46AA-A723-72E3EC331FF4Q35094769-07D48FC8-4B04-445E-8381-37AADDEB71B3Q35121532-720ABC13-C11E-47F2-BBF1-7AC7B7CDF61CQ35573137-CDED7FA7-C3EE-4B1B-B14B-C7EF61DCA68EQ35576138-8D09A6F0-6344-4AEE-AD15-B03781AE3DCEQ35664565-66C3DFE1-0E1A-4A04-9323-D7AEF75DE967Q35680192-C94AACF6-FB58-421C-A01E-39E975766AF2Q36188662-F4D5A00C-7025-4C59-908C-001B36C6C9EEQ36192823-E32B57BF-AF2C-4876-9865-4E253340274EQ36352165-75E0C83C-0BC4-4B4D-B4B0-A75DC314F909Q36472396-82A59804-495F-4BF3-8F14-ED50CCD7CBB7Q36497887-79604A63-CCC2-4F16-B666-C6946F8FA7EFQ36875566-DD150F49-C66C-451C-A9B8-2BA65CB7B177Q36930970-0CA03446-A750-4985-BDEB-F6CE0F22B1C7Q37152486-D3F2942B-0B85-4B79-907A-44FBA221CEE1Q37331941-5A5DA23C-0CAB-4894-84AC-4907DD6E1C09Q37356778-A4934DC6-15A6-4F54-8F88-C98B88C533E3Q37374441-A8A09A85-1143-47CB-B9E3-DC896DFEBF85Q37421212-ECAE0B2F-8F8D-4247-BD79-2D49748507EDQ37455276-98EC48ED-32C5-41EA-BBEA-C749CD69A764Q37502281-864D70E0-CE26-4373-AF05-9DD59CACC661Q37604889-D2F685D6-8EF8-4E14-9C74-59B799A073C0Q37786510-3F208958-6FC9-4040-8215-D25AD424DC4AQ37939057-904D28C8-3846-4A3F-97E8-20673B903B65Q37986358-9734F158-9E89-42C2-9AF3-E21174DD3078
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul Cockwell
@ast
Paul Cockwell
@en
Paul Cockwell
@es
Paul Cockwell
@nl
Paul Cockwell
@sl
type
label
Paul Cockwell
@ast
Paul Cockwell
@en
Paul Cockwell
@es
Paul Cockwell
@nl
Paul Cockwell
@sl
prefLabel
Paul Cockwell
@ast
Paul Cockwell
@en
Paul Cockwell
@es
Paul Cockwell
@nl
Paul Cockwell
@sl
P106
P21
P31
P496
0000-0003-1975-266X